ASPSCR1 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: Nevertheless, shared inflammatory/immune signatures between murine and human tRCC suggest that the Sglt2-Cre; ASPSCR1-TFE3LSL/+ model could be used for immunotherapy development, and the early development of tumors makes these experiments possible.